Human epicardial adipose tissue: A review

2007/05/30 by Harold S. Sacks, John N. Fain · 31 citations
Medicine · #Cardiovascular Disease and Adiposity #Cardiovascular, Neuropeptides, and Oxidative Stress Research

paper · doi:10.1016/j.ahj.2007.03.019

Cited by

• Epicardial fat and coronary artery disease: Role of cardiac imaging
• Perivascular adipose tissue as a cause of atherosclerosis
• Coronary perivascular adipose tissue characteristics are related to atherosclerotic plaque size and composition. A post-mortem study
• Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or peri-coronary location
• Multi-modal refinement of the human heart atlas during the first gestational trimester
• Epicardial adipose tissue and subclinical incident atrial fibrillation as detected by continuous monitoring: a cardiac magnetic resonance imaging study
• Validation of cardiovascular magnetic resonance assessment of pericardial adipose tissue volume. [europepmc]
• Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. [europepmc]
• Adaptive immunity and adipose tissue biology. [europepmc]
• Vascular effects of exercise: endothelial adaptations beyond active muscle beds. [europepmc]
• Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. [europepmc]
• Perivascular adipose tissue: more than just structural support. [europepmc]
• Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. [europepmc]
• Cardiac steatosis and left ventricular function in men with metabolic syndrome. [europepmc]
• Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects. [europepmc]
• Links between ectopic fat and vascular disease in humans. [europepmc]
• Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease. [europepmc]
• Mitochondria: a new therapeutic target in chronic kidney disease. [europepmc]
• Epicardial and paracardial adipose tissue volume and attenuation - Association with high-risk coronary plaque on computed tomographic angiography in the ROMICAT II trial. [europepmc]
• Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study. [europepmc]
• Regulation of Coronary Blood Flow. [europepmc]
• Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study. [europepmc]
• Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus. [europepmc]
• Epicardial adipose tissue density and volume are related to subclinical atherosclerosis, inflammation and major adverse cardiac events in asymptomatic subjects. [europepmc]
• The effect of dapagliflozin treatment on epicardial adipose tissue volume. [europepmc]
• Epicardial fat in heart failure patients with mid-range and preserved ejection fraction. [europepmc]
• Lipoxidation in cardiovascular diseases. [europepmc]
• Obesity and Atrial Fibrillation: Epidemiology, Pathophysiology and Novel Therapeutic Opportunities. [europepmc]
• The Complex Interactions Between Obesity, Metabolism and the Brain. [europepmc]
• Fully Automated CT Quantification of Epicardial Adipose Tissue by Deep Learning: A Multicenter Study. [europepmc]
• Pericardial Fat and the Risk of Heart Failure. [europepmc]